Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
855.7 USD | +0.67% | +3.11% | +47.03% |
01:00pm | US FDA advisers to review Eli Lilly Alzheimer's drug | RE |
12:55pm | Eli Lilly Study Shows Tirzepatide Superior to Placebo | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+47.03% | 765B | |
-5.99% | 354B | |
+20.18% | 331B | |
+8.90% | 299B | |
+19.00% | 248B | |
-1.72% | 219B | |
+11.04% | 216B | |
+5.50% | 164B | |
-2.55% | 162B | |
-0.10% | 123B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- JPMorgan Raises Eli Lilly's Price Target to $850 From $775, Maintains Overweight Rating